Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 1.81% | 174.66 | 1.2% | $575.79m | |
| CELG | Celgene Corporation | 0.60% | 89.49 | 1.2% | $535.84m | |
| GILD | Gilead Sciences, Inc. | 0.42% | 74.01 | 0.9% | $421.63m | |
| BIIB | Biogen Inc. | -1.41% | 259.30 | 1.2% | $416.64m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.56% | 316.01 | 2.7% | $245.42m | |
| INCY | Incyte Corporation | -0.42% | 68.14 | 2.5% | $245.05m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.34% | 158.69 | 1.9% | $226.49m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.05% | 107.83 | 2.0% | $209.17m | |
| NKTR | Nektar Therapeutics | -0.88% | 85.45 | 6.0% | $201.71m | |
| ILMN | Illumina, Inc. | 0.51% | 245.85 | 3.5% | $184.02m | |
| A | Agilent Technologies, Inc. | 0.74% | 68.05 | 1.5% | $157.16m | |
| ALNY | Alnylam Pharmaceuticals, Inc | -1.66% | 95.86 | 9.8% | $140.19m | |
| BLUE | Bluebird Bio, Inc. | -1.32% | 168.25 | 15.8% | $127.75m | |
| EXAS | Exact Sciences Corporation | 2.48% | 48.70 | 25.7% | $111.34m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.27% | 82.08 | 4.4% | $104.77m |
Company Profile
Blueprint Medicines Corp. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes BLU-285 and BLU-554 for the treatment of gastrointestinal stromal tumors, systemic mastocytosis, and leukemia. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy in October 2008 and is headquartered in Cambridge, MA.